Study to Evaluate Pharmacokinetic and Safety of Albuvirtide Between Intravenous Drip and Intravenous Injection
Clinical trial NCT05206019 · COMPLETED
Trial details
- NCT number
- NCT05206019
- Sponsor
- Frontier Biotechnologies Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-16
- Primary completion
- 2022-04-17
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.